The Biotech Investment National Security Act of 2026 aims to enhance U.S. national security by addressing concerns related to biotechnology and its potential misuse by foreign entities, particularly from China. The main objective is to prevent U.S. investments in biotechnology from inadvertently supporting China's efforts to dominate this critical sector, which has implications for both national security and public health.